Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$7.8 - $16.13 $439,920 - $909,732
-56,400 Reduced 79.32%
14,700 $152,000
Q3 2018

Nov 14, 2018

SELL
$14.31 - $17.65 $55,809 - $68,835
-3,900 Reduced 5.2%
71,100 $1.31 Million
Q2 2018

Aug 14, 2018

BUY
$11.83 - $16.2 $887,250 - $1.22 Million
75,000 New
75,000 $1.43 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $230M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.